These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9505221)

  • 41. [Neutropenic colitis. A case report].
    Sinibaldi G; Covizzi M; Corbascio D
    Minerva Chir; 1997; 52(7-8):975-7. PubMed ID: 9411303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvant and neoadjuvant therapy in non-small cell lung cancer.
    Belani CP
    Semin Oncol; 2005 Apr; 32(2 Suppl 2):S9-15. PubMed ID: 15818538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer.
    Gutierrez-Sainz L; Cruz-Castellanos P; Higuera O; de Castro-Carpeño J
    Curr Treat Options Oncol; 2021 Aug; 22(10):91. PubMed ID: 34424417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitoxantrone in the treatment of metastatic transitional cell carcinoma of the prostate. A case report.
    Stewart DJ; Dahrouge S
    Am J Clin Oncol; 1997 Aug; 20(4):381-2. PubMed ID: 9256894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy in stage I+II non-small cell lung cancer.
    Ukena D
    Lung Cancer; 2001 Sep; 33 Suppl 1():S25-8. PubMed ID: 11576704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant vs neoadjuvant chemotherapy in resectable NSCLC: is that the real question?
    Strauss GM
    Oncology (Williston Park); 2009 May; 23(6):534-6, 538. PubMed ID: 19544695
    [No Abstract]   [Full Text] [Related]  

  • 47. Breakthrough test for lung cancer therapy. New test can predict whether patient will benefit from post-surgery chemotherapy.
    Duke Med Health News; 2008; Suppl():7-8. PubMed ID: 18998609
    [No Abstract]   [Full Text] [Related]  

  • 48. Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer.
    Betticher DC; Rosell R
    Lung Cancer; 2004 Dec; 46 Suppl 2():S23-32. PubMed ID: 15698528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of vindesine as neoadjuvant chemotherapy for non-small cell lung and head and neck cancers.
    Cvitkovic E; Wasserman E
    Anticancer Drugs; 1997 Sep; 8(8):734-45. PubMed ID: 9396617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with 
Chemotherapy in Resectable Non-small Cell Lung Cancer].
    Zhou S; Hao X; Yu D; Liu S; Cao X; Su C; Song X; Xiao N; Li Y; Yang W; Zhao D; Wang J; Liu Z; Xu S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):420-425. PubMed ID: 34024062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. More questions about neoadjuvant chemotherapy in lung cancer.
    Vallières E
    Oncology (Williston Park); 2009 Sep; 23(10):892, 896. PubMed ID: 19839431
    [No Abstract]   [Full Text] [Related]  

  • 52. Challenges of preoperative chemotherapy in non-small cell lung cancer.
    Johnson DH
    Lung Cancer; 1994 Mar; 10 Suppl 1():S195-203. PubMed ID: 8087511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neoadjuvant chemotherapy of non-small cell bronchial cancers].
    Pujol JL; Michel FB
    Presse Med; 1991 Mar; 20(9):418-22. PubMed ID: 1850133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term survival after bilateral adrenalectomy for metastatic lung cancer: a case report.
    Urschel JD; Finley RK; Takita H
    Chest; 1997 Sep; 112(3):848-50. PubMed ID: 9315827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perioperative Therapy for Resectable Non-Small-Cell Lung Cancer: Weighing Options for the Present and Future.
    Uprety D; West HJ
    JCO Oncol Pract; 2023 Jul; 19(7):403-409. PubMed ID: 37023371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New strategies in the treatment of resectable non-small cell lung cancer.
    Felip E; Rosell R
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):224-8. PubMed ID: 12113027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The role of adjuvant chemotherapy in operable non-small cell lung cancer].
    Yan X; Zhu H; Wang H; Wang Q; Li P; Ma Z
    Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):281-5. PubMed ID: 21426675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Assessment of the clinical symptoms and treatment tolerance in patients with non-small cell lung cancer (NSCLC) undergoing first-line chemotherapy and pulmonary rehabilitation].
    Tokarski S; Obrebska A; Mejer A; Kowalski J
    Pol Merkur Lekarski; 2014 Apr; 36(214):245-8. PubMed ID: 24868896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab.
    Ruck JM; Broderick SR
    Ann Surg Oncol; 2024 Jan; 31(1):4-5. PubMed ID: 37884698
    [No Abstract]   [Full Text] [Related]  

  • 60. [Informed consent of the family in the chemotherapy for lung cancer].
    Tazawa H; Satoh I; Ishihara J; Ohmori T; Horichi N; Kashima N; Hiraizumi T; Takahashi T; Yamamoto M; Kasahara K
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1448-53. PubMed ID: 2170548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.